125 related articles for article (PubMed ID: 28452726)
1. [NESFATIN-1 ACTIVITY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PREDIABETES, TYPE 2 DIABETES].
Kovalyova O; Ashcheulova T; Demydenko A; Vizir M; Kochubiei O
Georgian Med News; 2017 Feb; (263):44-49. PubMed ID: 28452726
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional correlates of nesfatin and lipopolysaccharide binding protein in metabolic syndrome patients with and without prediabetes.
Al-Qudah SA; Kasabri V; Saleh MI; Suyagh M; AlAlawi S; Yasin N
Horm Mol Biol Clin Investig; 2018 Sep; 36(3):. PubMed ID: 30205641
[TBL] [Abstract][Full Text] [Related]
3. Nesfatin-1 correlates with hypertension in overweight or obese Han Chinese population.
Zhao Y; Ma X; Wang Q; Zhou Y; Zhang Y; Wu L; Ji H; Qin G; Lu J; Bi Y; Ning G
Clin Exp Hypertens; 2015; 37(1):51-6. PubMed ID: 24678977
[TBL] [Abstract][Full Text] [Related]
4. Nesfatin-1 role in remodeling of the left ventricle myocardium in patients with arterial hypertension and obesity.
Shaparenko OV; Kravchun PG; Kravchun PP; Kadykova OI
Wiad Lek; 2018; 71(5):1006-1009. PubMed ID: 30176631
[TBL] [Abstract][Full Text] [Related]
5. Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.
Guo Y; Xing M; Sun W; Yuan X; Dai H; Ding H
Acupunct Med; 2014 Aug; 32(4):313-7. PubMed ID: 24813558
[TBL] [Abstract][Full Text] [Related]
6. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance.
Anwar GM; Yamamah G; Ibrahim A; El-Lebedy D; Farid TM; Mahmoud R
Regul Pept; 2014 Jan; 188():21-4. PubMed ID: 24333832
[TBL] [Abstract][Full Text] [Related]
7. Serum nesfatin-1 levels in patients with different glucose tolerance levels.
Algul S; Ozkan Y; Ozcelik O
Physiol Res; 2016 Dec; 65(6):979-985. PubMed ID: 27539099
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of leptin, nesfatin-1 and kisspeptin in postmenopausal obese women.
Çelik F; Belviranli M; Okudan N
Arch Physiol Biochem; 2016 Oct; 122(4):195-199. PubMed ID: 27011110
[TBL] [Abstract][Full Text] [Related]
9. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.
Abaci A; Catli G; Anik A; Kume T; Bober E
Pediatr Diabetes; 2013 May; 14(3):189-95. PubMed ID: 23346951
[TBL] [Abstract][Full Text] [Related]
10. Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects.
Mirzaei K; Hossein-nezhad A; Keshavarz SA; Koohdani F; Eshraghian MR; Saboor-Yaraghi AA; Hosseini S; Chamari M; Zareei M; Djalali M
Diabetes Metab Syndr; 2015; 9(4):292-8. PubMed ID: 25470645
[TBL] [Abstract][Full Text] [Related]
11. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.
Hofmann T; Stengel A; Ahnis A; Buße P; Elbelt U; Klapp BF
Psychoneuroendocrinology; 2013 Nov; 38(11):2502-10. PubMed ID: 23796625
[TBL] [Abstract][Full Text] [Related]
12. Circulating Nesfatin-1 Levels and Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Zhai T; Li SZ; Fan XT; Tian Z; Lu XQ; Dong J
J Diabetes Res; 2017; 2017():7687098. PubMed ID: 29445751
[TBL] [Abstract][Full Text] [Related]
13. A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.
Başar O; Akbal E; Köklü S; Koçak E; Tuna Y; Ekiz F; Gültuna S; Yιlmaz FM; Aydoğan T
Scand J Clin Lab Invest; 2012 Oct; 72(6):479-83. PubMed ID: 22950627
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome.
Aksu O; Aydın B; Doguç DK; Ilhan I; Ozturk O; Altuntas A; Demirkan H; Koroglu BK; Tamer MN
J Endocrinol Invest; 2015 Apr; 38(4):463-9. PubMed ID: 25432328
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus.
Zhang Z; Li L; Yang M; Liu H; Boden G; Yang G
Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):91-5. PubMed ID: 22020667
[TBL] [Abstract][Full Text] [Related]
16. Nesfatin-1 hormone levels in morbidly obese patients after laparoscopic sleeve gastrectomy.
Dogan U; Bulbuller N; Cakır T; Habibi M; Mayir B; Koc U; Aslaner A; Ellidag HY; Gomceli I
Eur Rev Med Pharmacol Sci; 2016; 20(6):1023-31. PubMed ID: 27049252
[TBL] [Abstract][Full Text] [Related]
17. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity.
Anık A; Çatlı G; Abacı A; Küme T; Bober E
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):623-8. PubMed ID: 24825087
[TBL] [Abstract][Full Text] [Related]
18. Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.
Ding S; Qu W; Dang S; Xie X; Xu J; Wang Y; Jing A; Zhang C; Wang J
Med Sci Monit; 2015 Apr; 21():987-91. PubMed ID: 25841171
[TBL] [Abstract][Full Text] [Related]
19. Alterations of circulating NUCB2/nesfatin-1 during short term therapeutic improvement of anxiety in obese inpatients.
Hofmann T; Weibert E; Ahnis A; Obbarius A; Elbelt U; Rose M; Klapp BF; Stengel A
Psychoneuroendocrinology; 2017 May; 79():107-115. PubMed ID: 28273586
[TBL] [Abstract][Full Text] [Related]
20. Association between nesfatin-1 levels and metabolic improvements in severely obese patients who underwent biliopancreatic derivation with duodenal switch.
St-Pierre DH; Martin J; Shimizu H; Tagaya Y; Tsuchiya T; Marceau S; Biertho L; Bastien M; Caron-Cantin SM; Simard S; Richard D; Cianflone K; Poirier P
Peptides; 2016 Dec; 86():6-12. PubMed ID: 27681383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
